Phase 1/11 Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of oral and Long- Acting Injectable Cabotegravir and Long -Acting Injectable Rilpivirine in Virologically Suppressed HIV- Infected Children and Adolescents ‘MOCHA’ (More Options for Children and Adolescents)